NCR Inks Agreement With PayPal and 3 Stocks Hitting 52-Week Highs

Becton Dickinson and Company (NYSE:BDX): Closing price $82.70

Becton Dickinson’s segment BD Medical said that the FDA has approved the BD PhaSeal Closed System Transfer Device under the newly created ONB code. The BD PhaSeal System is the first and sole approved CSTD under the new code, which was created for devices having specific indications for use with antineoplastic and other hazardous drugs. The FDA clearance was based on three criteria: no transfer of environmental contaminants, no escape of hazardous drug or vapor concentration, and prevention of microbial ingress. Shares closed up 0.49 percent on the day at $82.70, and have been traded in a 52-week range of $71.56 to $82.31.


Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!